17α-甲基雌二醇
化合物
17α-甲基雌二醇(英語:17α-Methylestradiol,缩写17α-Me-E2,商品名有Ginecosid、Ginecoside、Mediol和Renodiol)是一种雌激素类药物,可用于治疗更年期综合症[2][3][4][1]。
![]() | |
![]() | |
臨床資料 | |
---|---|
商品名 | Ginecosid, Ginecoside, Mediol, Renodiol |
其他名稱 | NSC-52245; 17α-Methylestradiol; 17α-ME; 17α-Methylestra-1,3,5(10)-triene-3,17β-diol |
给药途径 | By mouth[1] |
藥物類別 | Estrogen |
识别信息 | |
| |
CAS号 | 302-76-1 ![]() |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.005.572 |
化学信息 | |
化学式 | C19H26O2 |
摩尔质量 | 286.42 g·mol−1 |
3D模型(JSmol) | |
| |
|
另见
参考文献
- ^ 1.0 1.1 HEGEMANN O. [Oral hormonal treatment with methylestrene-olone & methylestradiol as early pregnancy tests]. Medizinische. May 1959, 4 (21): 1032–3. PMID 13673847 (德语).
- ^ J. Elks. The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. 14 November 2014: 898– [2021-06-27]. ISBN 978-1-4757-2085-3. (原始内容存档于2021-04-18).
- ^ Drugs.com. Methylestradiol. [2 January 2016]. (原始内容存档于2017-09-26).
- ^ IARC Working Group on the Evaluation of Carcinogenic Risks to Humans; World Health Organization; International Agency for Research on Cancer. Combined Estrogen-progestogen Contraceptives and Combined Estrogen-progestogen Menopausal Therapy. World Health Organization. 2007: 389– [2021-06-27]. ISBN 978-92-832-1291-1. (原始内容存档于2021-07-05).